curacle co.,ltd. (KOSDAQ:365270)
South Korea · Delayed Price · Currency is KRW 15,040
+890 (6.29%)
At close: Apr 1, 2026
curacle co.,ltd. Market Cap
curacle co.,ltd. has a market cap or net worth of 320.41 billion as of April 2, 2026. Its market cap has increased by 203.20% in one year.
Market Cap
320.41B
Enterprise Value
309.73B
Revenue
7.10M
Ranking
n/a
PE Ratio
n/a
Stock Price
15,040.00
Market Cap Chart
Since July 22, 2021, curacle co.,ltd.'s market cap has decreased from 409.36B to 320.41B, a decrease of -21.73%. That is a compound annual growth rate of -5.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 295.70B | 97.40% |
| Dec 30, 2025 | 149.80B | 79.35% |
| Dec 30, 2024 | 83.52B | -48.17% |
| Dec 28, 2023 | 161.14B | 2.54% |
| Dec 29, 2022 | 157.15B | -49.31% |
| Dec 30, 2021 | 310.02B | -24.27% |
| Jul 22, 2021 | 409.36B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kanaph Therapeutics | 542.86B |
| HansBiomed | 516.97B |
| Y-Biologics | 502.39B |
| S.Biomedics | 402.52B |
| TiumBio | 359.70B |
| Kangstem Biotech | 316.02B |
| NIBEC | 312.56B |
| Genome & Company | 307.06B |